Three major biomarkers used in diagnosing and treating bladder cancer include Bladder Tumor Antigen (BTA) STAT, BTA TRAK, and Nuclear Matrix Protein 22 (NMP22) (1, 49). The gene discussed is NUMA1; the disease is urinary bladder cancer.